戻る Agenda
A Hot Debate: Perspectives on Benefit and Risk From Patients Across Diseases
Session Chair(s)
Deborah Collyar
President
Patient Advocates In Research (PAIR), United States
This session provides a look at how regulators, companies, and patients can work together to discuss the benefits and risks of emerging products that can lead to better patient outcomes.
Learning Objective : Describe how regulators incorporate patient preferences into benefit/risk assessment; Identify how international efforts are building methodology for patient preferences and input into development, using case study examples.
Speaker(s)
Benefit- Risk Communication: Lessons from Patients
Dinah Duarte, MSC
European Medicines Agency, Netherlands
Signal Management Lead
PREFERing to Advocate for Patient Preferences
Rebecca Noel, DrPH, MPH
Eli Lilly, United States
Executive Director, Benefit-Risk Assessment